RTI Health Solutions
@RTIHS
Followers
1K
Following
1K
Media
1K
Statuses
8K
From clinical to post-market - integrated #heor and #epi #research services for #pharma and #meddevice. Unit of @RTI_Intl. Find us @rti-hs.bsky.social
USA-Spain-Sweden-UK-France
Joined December 2012
Health technology assessment - Joint clinical assessments of medicinal products | European Commission #hta #healthtechnologyassessment #healthtech #EMA.
ec.europa.eu
European Commission - Have your say
3
0
2
RT @RTI_HealthAdv: We're excited to announce that we have joined our RTI Health Solutions colleagues under the RTI Health Solutions brand.….
0
1
0
If you are attending #ICPE23, visit us at booth #1000, chat with our researchers, and scan your badge to be entered to win one of three copies of Modern Epidemiology: 4th Edition, coauthored by RTI Health Solutions expert Kenneth Rothman.
rtihs.org
ICPE 2023: The Global Home for the Science of Real-World Evidence
0
0
2
We're attending! And here's what we'll be bringing -
rtihs.org
ICPE 2023: The Global Home for the Science of Real-World Evidence
We are ONE MONTH away from the much-anticipated #ICPE23 in Halifax! Who all are we going to see there? Comment below with "I'm attending!" if you're going to be there August 23-27. #PharmEpi #EpiTwitter #Pharmacoepidemiology
0
0
2
Medtech companies - looking for budget-friendly value assessment & evidence gap analysis? RTI-HS is a certified NICE META tool facilitator. Let's see if this tool is right for your product. #digitalhealth.
0
1
0
Looking for a team with proven performance, adherence to ISPOR and WHO best practices, and a wide range of experience to assist you with #infectiousdisease modeling? Take a look at our qualifications.
0
0
0
See research on how ICER'S evidence ratings are determined. #healthcare #research #costeffectiveness.
rtihs.org
A systematic review of ICER'S evidence ratings for new drugs in 2020-2021
0
0
0
RTI is proud to have earned the 2023 Military Friendly® Employer designation. #diversity #inclusion
0
0
3
-How HRQOL data analysis pooled across multiple trials demonstrated extended time to deterioration in quality of life for oncology product. Read the case study->#biostatistics.
0
0
0
Challenged with developing pre-approval information exchange (PIE) materials? We can help you communicate key pre-approval information about your medtech or #drugdevelopment. #GVD.
0
0
0
We can help you identify potential gaps in your evidence and create a plan to address them—saving you time and costly re-work down the road. #pharma #CRO #drugresearch.
rtihs.org
0
0
0
Have you seen our case study on determining the long-term benefits of a therapy slowing kidney function decline without long-term clinical trials? Read it here->#kidneyresearch #kidneyfunction.
0
0
0
Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in Rare Disease and #GeneTherapy. Learn more @DrugInfoAssn #RWD #RWE #pharma.
rtihs.org
RTI Health Solutions research experts will be participating in the schedule of events at #DIA2023. Their programs will cover post-market pregnancy requirements and safety in rare disease and gene...
0
0
0
Our approach to providing analysis results in a consistent format across trials allows clients to easily incorporate results in reports, submissions, and publications. #HTA #pharmaceutical
0
0
0
Our experts will be participating in two forums at #DIA2023: Post-Market Pregnancy Requirements, and Assessing Safety in #RareDisease and Gene Therapy. Learn more @DrugInfoAssn #biotech @pregnancyresearch.
rtihs.org
RTI Health Solutions research experts will be participating in the schedule of events at #DIA2023. Their programs will cover post-market pregnancy requirements and safety in rare disease and gene...
0
0
1
Research we've coauthored, Preferences for oral antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. @ISBD4.
rtihs.org
Research coauthored by RTI Health Solutions researchers will be presented at the 2023 ISBD Annual Conference. Doane MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Gasper S, Citrome L, Sajatovic M....
0
0
1
Research we've coauthored, Preferences for oral #antipsychotic treatments: survey of patients living with bipolar I disorder, will be presented at #ISBD2023. @ISBD4 #BipolarResearch.
rtihs.org
Research coauthored by RTI Health Solutions researchers will be presented at the 2023 ISBD Annual Conference. Doane MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Gasper S, Citrome L, Sajatovic M....
0
0
1
RT @RTI_Intl: 🏳🌈 This month, RTI is honoring #Pride2023 by celebrating our Pride Employee Resource Group (ERG). Join us as we listen to ou….
0
1
0